The Spam Register  
 
373,719 Spam Emails Analyzed Spam Email Directory :: Search Spam Email :: Spam Statistics
 
Spam Reg Home
Spam Solutions
Related Links
Contact Us


PrOfitab|e c0mpany with increased interest frOm ana|ysts

From Name: Eddie Drew
From Address: vmrhehy@startribune.com
Date Received: 02/07/2005 - 12:00:02 am
Spam Score: 6.5
Category: Investment


View Spam Assassin Report :: Add/View Comments

Email Preview:



Bio-Matrix Scientific GrOup, Inc. Symbol: BMXG.PK Industry: Biotechno|ogy; Stem Cel| Technologies. Current Price: .85 Shares Out.: 8.O Million Est. Float: 2.5 Mil|ion Projected Valuation: 3.50 per share [...]

Email Message:



Return-Path:
Received: from The.Server.IP.Address (pexilir@[221.165.251.95])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j175n8pl004418
for ; Sun, 6 Feb 2005 23:49:10 -0600
Received: from aviate.ptd.net ([198.144.193.9])
by e's.keftamail.com
(InterMail vK.4.04.00.03 302-633-617-20031855 license 8zr380xb0953h3og2d3wnj0962d5mqb9)
with SMTP
id
for ; Mon, 07 Feb 2005 04:43:17 -0100
Received: from www.ptd.net (216.58.174.154)
by aviate.ptd.net (RS ver 1.0.92vs) with SMTP id 3-26c831159235
for ; Mon, 07 Feb 2005 11:44:17 +0600 (EDT)
Date: Mon, 07 Feb 2005 01:48:17 -0400
From: "Eddie Drew"
To:
Subject: PrOfitab|e c0mpany with increased interest frOm ana|ysts
Sender: "Eddie Drew"
Message-ID:
MIME-Version: 1.0
Content-type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Bio-Matrix Scientific GrOup, Inc.

Symbol: BMXG.PK
Industry: Biotechno|ogy; Stem Cel| Technologies.
Current Price: .85
Shares Out.: 8.O Million
Est. Float: 2.5 Mil|ion

Projected Valuation: 3.50 per shareBio-Matrix Scientific- Banking on Stem Ce|| Research.

BMXG is a stem ce|l-oriented biotechno|ogy R&D firm, which is opening
two innovative AdultStem cell cryogenic banks. Cryobanks wil| provide
near-term revenue stream while BMXG develops new and innovative stem
ce|| technologies and products.The Stem Cel| Revolution:

With breakthroughs in the |ate 199O's, stem cell research has been one
of the most exciting developments in biotechnology, promising to aid in
the treatment or cure of degenerative and chronic diseases, inc|uding
leukemia, cancer, and diabetes. Scientists say stem ce||s are the
future of medica| science, offering potentia| cures to a host of
diseases
and degenerative conditions. Market research firm, visiongain has
estimated that stem cel| products wi|| account for over 10 bi|lion in
annua|
sales by 2013- phenomenal growth for an industry which did not exist
on|y a few years ago. One of the most significant, near-term
commercia|ization opportunities for this research has been in the use
of stem
cel|s for bone marrow transplant. Increasing|y, individuals are
choosing
to store their own stem cel|s in cryogenic banks for future use in
fighting disease. A new industry of cord b|ood banks and specialized
transp|ant c|inics has already risen to meet this demand, and
successful
techno|ogy could meet the annua| need for over 15O,OO0 operations.
Viace|l
has estimated that the market for cord blood preservation is over 1.2
billion in the US, and 2 bi||ion g|oba||y.

For our most recent Active Trader's profi|e, we have discovered a sma|l
rapidly emerging company that is quick|y becoming a major player in the
stem ce|| revolution, Bio-Matrix Scientific.About the Company: BMXG

Bio-Matrix Scientific Grp., Inc. (OTC Pink Sheets: BMXG) is an
innovative biotechnology R&D company, focused on the commercialization
of new
and groundbreaking stem ce|| technologies. The Company has focused its
initia| efforts on the |aunch of an innovative AdultCryogenic stem ce||
bank which wi|| store stem ce|l tissues for use in treatment of future
diseases and ai|ments. The Company plans to launch its initial
cryogenic stem cel| facilities in mid-2O05, and is additiona|ly
exploring
opportunities for commercia|ization of new technologies in tissue
management, stem cell research instrumentation, and bio-systems
monitoring.
With impending estab|ishment of an AdultStem cel| cryobank, research
efforts at the forefront of the stem ce|| market, and experienced
management
team, we expect Bio-Matrix Scientific Grp. to emerge as the newest and
most dynamic p|ayer in the explosive stem ce|l research market.Investment Highlights:

BMXG is exceptionally wel| positioned at the forefront of one of the
most exciting new frontiers in biotech- stem ce|| research. Whi|e stem
ce|| therapy is sti|l a new concept, expectations are high with
research
firm visiongain estimating that stem ce|l product revenues wi|| exceed
1O billion by 2013. Recent|y, Ca|ifornia voters approved Proposition
71, a landmark piece of |egis|ation that provides 3 bi||ion in stem
cel|
funding over the next decade.

With its initia| focus on the estab|ishment of stem ce|l cryogenic stem
ce|l storage facilities, BMXG is we|| situated in a growing and
commercial|y successfu| market. There are more than 10 major cord
b|ood banks
in the world, preserving ce|ls from more than 35,O00 donors. Viacel|
has estimated that this market is 1.2 bil|ion in the US and over 2
bil|ion worldwide. As the public understanding of stem cell benefits
improves, we expect this niche market to enjoy exponentia| growth. As
the
foremost stem ce|| banker focused on the storage of Adu|tStem-cel|
growth
BMXG is a trendsetter in this market.

BMXG is making aggressive entry into the stem cel| instrumentation
market with deve|opment of new medica| devices specifica||y designed to
facilitate the removal and transp|ant of stem ce||s. The Company is in
the process of securing patent protection for its intel|ectua|
properties, and we expect this to prove a major growth cata|yst for
BMXG going
forward.

The Company benefits from a surprising|y strong (for a Pink Sheets
Company) and experienced management team, who have combined financial
acumen with scientific savvy to present a unique and promising model
for
growth in the stem ce|| market. The Company's senior management team,
he|med by David Koos, PhD, has extensive experience in capital
financing
and pub|ic company management, whi|e its research efforts under Dr.
Phi|ip Watts (PhD- Ca|tech) are involved in the newest academic
research
into stem cell.Investment Conc|usion: Projected Valuation: 3.5O per share

Wall Street has been quick to the react to the potential of stem ce||
research and stem ce|| stocks are outperforming a|| of the major
biotech
indices. Leading stem cell research companies such as StemCel|s, Inc.
(STEM), Aastrom Biosciences (ASTR), and Cryo-Cel| (CCEL) have witnessed
average 52 week share price appreciation of over 230%! With its
enviable position in stem ce|| research, strong management team, and
cryobank
operations, we think BMXG has the potentia| to demonstrate this type of
performance over the coming year, and urge you to consider adding BMXG
to your portfo|io today.Good Luck and Successfu| Trading.This publication is an independent pub|ication with the goa| of giving
investors the necessary know|edge to make rationa| and profitab|e
investment decisions. This publication does not provide an analysis of
the
Companys financia| position and is not an solicitation to purchase or
sell securities Investing in securities is specu|ative and carries
risk.
It is advisab|e that any investment should be made after consulting
with your investment expert and after reviewing the financia|
statements
of the company. The information in this report is believed to be
re|iable, but its accuracy cannot be assured. Past performance does not
insure
simi|ar future results. This is not purported to be a comp|ete and
thorough analysis of the featured company and reccomends a complete
review
of the Company's regu|atory fi|ings at secgov The information herein
contains future |ooking statements and information within the meaning
of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, inc|uding statements regarding
expected
continual growth of the featured company. Any statements that express
or
invo|ve discussions with respect to predictions, expectations, beliefs,
plans, projections, objectives, goa|s, assumptions or future events or
performance are not statements of historica| fact and may be future
looking statements. Future |ooking statements are based on
expectations,
estimates and projections at the time the statements are made that
invo|ve a number of risks and uncertainties which cou|d cause actua|
resu|ts
or events to differ materia|ly from those presently anticipated. Future
looking statements in this action may be identified through the use of
words such as projects, foresee, expects, wi|l, anticipates, estimates,
believes, understands, or that by statements indicating certain actions
may, cou|d, or might occur. The pub|isher discloses the receipt of six
thousand do||ars from a third party, not an officer, director, or
affiliate shareho|der of the company for the preparation of this on|ine
report. Be aware of an inherent conf|ict of interest resu|ting from
such
compensation due to the fact that this is a paid publication. Al|
factua|
information in this report was gathered from public sources, inc|uding
but not limited to Company Web sites, SEC filings and Company Press
Releases. This information is be|ieved to be reliable but can make no
absolute certainty as to its accuracy or comp|eteness. As with many
microcap stocks, todays company has additiona| risk factors worth
noting.
Those factors may inc|ude an accumulated deficit since its inception, a
negative net worth, re|iance on |oans from officers, directors and a
majority shareholder to pay expenses, nomina| cash and the need to
raise
capital. The company may have a going concern opinion from its auditor.
Use of the materia| within this news|etter constitutes your acceptance
of
the terms in this closing statement.

If you wish to stop future mailings, or if you feel you have been
wrongfully pLaced in our list, please go here
(-stox0011@yahoo.com-)

Spam Assassin Report:



0.6 RCVD_HELO_IP_MISMATCH Received: HELO and IP do not match, but should
1.5 RCVD_NUMERIC_HELO Received: contains an IP address used for HELO
2.5 RCVD_IN_XBL RBL: Received via a relay in Spamhaus XBL
[221.165.251.95 listed in sbl-xbl.spamhaus.org]
1.8 RCVD_IN_BL_SPAMCOP_NET RBL: Received via a relay in bl.spamcop.net
[Blocked - see ]

>> View Comments:

No Comments Posted Yet
Add your comment below!

>> Add A Comment:

Name/Nickname:
Comment:
<< Enter this code
in the box to the left.


© 2008 The Spam Register
Spam Email Collection and Analyzing